Related Experiment Video
Updated: Sep 30, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Mean platelet volume and coronary heart disease in hemodialysis patients
Bernard F Henning1, Walter Zidek, Bertolt Linder
1Medizinische Klinik I, Universitätsklinik Marienhospital, Ruhr-Universität Bochum, Herne, Germany. bernhard.henning@ruhr-uni-bochum.de
Insights
Mean platelet volume (MPV) is linked to coronary heart disease (CHD) in hemodialysis patients. Higher MPV levels correlate with increased CHD risk, suggesting MPV as a potential biomarker in this population.
Area of Science:
- Nephrology
- Cardiology
- Hematology
Background:
- Mean platelet volume (MPV) is an established independent risk factor for myocardial infarction in the general population.
- Chronic kidney disease patients on hemodialysis often exhibit altered platelet indices.
- Understanding platelet behavior in hemodialysis is crucial for cardiovascular risk assessment.
Purpose of the Study:
- To investigate the association between Mean platelet volume (MPV) and coronary heart disease (CHD) in patients undergoing chronic hemodialysis.
- To determine if MPV serves as an independent predictor of CHD in this specific patient cohort.
Main Methods:
- A cross-sectional study involving 518 patients on chronic hemodialysis.
- Coronary heart disease (CHD) was defined by a history of myocardial infarction, coronary artery bypass grafting, or significant coronary artery stenosis on angiography.
- Statistical analyses included logistic regression to identify independent predictors of CHD.
Main Results:
- Hemodialysis patients had a mean MPV of 8.22 +/- 0.06 fL.
- Patients in the upper quintile of MPV (>9.172 fL) had a significantly higher prevalence of CHD compared to those in the lower quintile (<7.168 fL) (OR, 1.29).
- MPV was identified as an independent factor for CHD, alongside age, smoking, systolic blood pressure, and serum triglyceride levels. MPV was also influenced by platelet count, ultrafiltration volume, white blood cell count, beta-blocker use, heart rate, and serum electrolytes.
Conclusions:
- Mean platelet volume (MPV) is associated with coronary heart disease (CHD) in patients undergoing chronic hemodialysis.
- MPV may serve as a valuable biomarker for assessing cardiovascular risk in hemodialysis patients.
Background:
Mean platelet volume (MPV) has been shown to be an independent risk factor for myocardial infarction in the general population.
Methods:
In the present cross-sectional study it was examined whether MPV may be associated with coronary heart disease (CHD) in patients in chronic hemodialysis treatment (n = 518). CHD was diagnosed if there was a history of myocardial infarction, coronary artery bypass grafting, or critical stenosis on coronary angiography.
Results:
Mean platelet volume in hemodialysis patients was 8.22 +/- 0.06 fl. As compared with hemodialysis patients with a MPV <7.168 fl (the lower quintile limit), significantly more hemodialysis patients with a MPV >9.172 fl (the upper quintile limit) had CHD (odds ratio, 1.29; 95% confidence interval, 1.02-1.64). In a stepwise multiple logistic regression analysis MPV appeared to be an independent factor of CHD together with age, smoking, predialysis systolic blood pressure and serum triglyceride concentration. In a stepwise multiple linear regression model, MPV significantly depended on platelet count, volume of ultrafiltrate removed in one hemodialysis session, white blood cell count, treatment with beta blockers, heart rate, serum sodium and serum potassium concentrations. Additional measurements in 30 patients showed that MPV after a single hemodialysis session was not significantly different compared to predialysis values.
Conclusion:
From the present study it is concluded that MPV may be associated with CHD in hemodialysis patients.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management
Peritoneal Dialysis III: Nursing Management
